{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:11:26Z","timestamp":1792714286605,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Patients with cancer are at higher risk of severe coronavirus infectious disease 2019 (COVID-19), but the mechanisms underlying virus\u2013host interactions during cancer therapies remain elusive. When comparing nasopharyngeal swabs from cancer and noncancer patients for RT-qPCR cycle thresholds measuring acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in 1063 patients (58% with cancer), we found that malignant disease favors the magnitude and duration of viral RNA shedding concomitant with prolonged serum elevations of type 1 IFN that anticorrelated with anti-RBD IgG antibodies. Cancer patients with a prolonged SARS-CoV-2 RNA detection exhibited the typical immunopathology of severe COVID-19 at the early phase of infection including circulation of immature neutrophils, depletion of nonconventional monocytes, and a general lymphopenia that, however, was accompanied by a rise in plasmablasts, activated follicular T-helper cells, and non-naive Granzyme B\n                    <jats:sup>+<\/jats:sup>\n                    FasL\n                    <jats:sup>+<\/jats:sup>\n                    , Eomes\n                    <jats:sup>high<\/jats:sup>\n                    TCF-1\n                    <jats:sup>high<\/jats:sup>\n                    , PD-1\n                    <jats:sup>+<\/jats:sup>\n                    CD8\n                    <jats:sup>+<\/jats:sup>\n                    Tc1 cells. Virus-induced lymphopenia worsened cancer-associated lymphocyte loss, and low lymphocyte counts correlated with chronic SARS-CoV-2 RNA shedding, COVID-19 severity, and a higher risk of cancer-related death in the first and second surge of the pandemic. Lymphocyte loss correlated with significant changes in metabolites from the polyamine and biliary salt pathways as well as increased blood DNA from Enterobacteriaceae and Micrococcaceae gut family members in long-term viral carriers. We surmise that cancer therapies may exacerbate the paradoxical association between lymphopenia and COVID-19-related immunopathology, and that the prevention of COVID-19-induced lymphocyte loss may reduce cancer-associated death.\n                  <\/jats:p>","DOI":"10.1038\/s41418-021-00817-9","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T10:04:49Z","timestamp":1625565889000},"page":"3297-3315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3431-3067","authenticated-orcid":false,"given":"Anne-Ga\u00eblle","family":"Goubet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7526-0769","authenticated-orcid":false,"given":"Agathe","family":"Dubuisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Geraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-Xavier","family":"Danlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safae","family":"Terrisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Alves Costa","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Drubay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Touri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Mazzenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymeric","family":"Silvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garett","family":"Dunsmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacine","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenie","family":"Pizzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Flament","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9a","family":"Melenotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8629-1341","authenticated-orcid":false,"given":"Eric","family":"Solary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Fontenay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Balleyguier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Lassau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Maeurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Grajeda-Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitharsshini","family":"Nirmalathasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Aprahamian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylv\u00e8re","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-9558","authenticated-orcid":false,"given":"Oliver","family":"Kepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys","family":"Ferrere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Thelemaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Lahmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6581-8418","authenticated-orcid":false,"given":"Jean-Eudes","family":"Fahrner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Meziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6489-5091","authenticated-orcid":false,"given":"Abdelhakim","family":"Ahmed-Belkacem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Sa\u00efdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"La Scola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Raoult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Cortaredona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1076-2979","authenticated-orcid":false,"given":"Giuseppe","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lelouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Roulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Andre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Barlesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Pradon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Gallois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Pommeret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Colomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2857-7755","authenticated-orcid":false,"given":"Florent","family":"Ginhoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Kazandjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielle","family":"Elkrief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Routy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Miyara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Gorochov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8223-3697","authenticated-orcid":false,"given":"Eric","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Albiges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Stoclin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Gachot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Florin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansouria","family":"Merad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Scotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souad","family":"Assaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9334-4405","authenticated-orcid":false,"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7190-120X","authenticated-orcid":false,"given":"Jean-Yves","family":"Blay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5816-3019","authenticated-orcid":false,"given":"Aur\u00e9lien","family":"Marabelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Griscelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1596-0998","authenticated-orcid":false,"given":"Laurence","family":"Zitvogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Derosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"key":"817_CR1","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s43018-020-00122-3","volume":"1","author":"L Derosa","year":"2020","unstructured":"Derosa L, Melenotte C, Griscelli F, Gachot B, Marabelle A, Kroemer G, et al. The immuno-oncological challenge of COVID-19. Nat Cancer. 2020;1:946\u201364.","journal-title":"Nat Cancer."},{"key":"817_CR2","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/s43018-020-00120-5","volume":"1","author":"L Albiges","year":"2020","unstructured":"Albiges L, Foulon S, Bayle A, Gachot B, Pommeret F, Willekens C, et al. Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort. Nat Cancer. 2020;1:965\u201375.","journal-title":"Nat Cancer."},{"key":"817_CR3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s43018-020-0104-9","volume":"1","author":"M Rugge","year":"2020","unstructured":"Rugge M, Zorzi M, Guzzinati S. SARS-CoV-2 infection in the Italian Veneto region: adverse outcomes in patients with cancer. Nat Cancer. 2020;1:784\u20138.","journal-title":"Nat Cancer."},{"key":"817_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejca.2020.05.028","volume":"135","author":"S Assaad","year":"2020","unstructured":"Assaad S, Avrillon V, Fournier M-L, Mastroianni B, Russias B, Swalduz A, et al. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR. Eur J Cancer. 2020;135:251\u20139.","journal-title":"Eur J Cancer."},{"key":"817_CR5","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.annonc.2020.06.007","volume":"31","author":"J Luo","year":"2020","unstructured":"Luo J, Rizvi H, Preeshagul IR, Egger JV, Hoyos D, Bandlamudi C, et al. COVID-19 in patients with lung cancer. Ann Oncol. 2020;31:1386\u201396.","journal-title":"Ann Oncol"},{"key":"817_CR6","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S1470-2045(20)30314-4","volume":"21","author":"MC Garassino","year":"2020","unstructured":"Garassino MC, Whisenant JG, Huang L-C, Trama A, Torri V, Agustoni F, et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020;21:914\u201322.","journal-title":"Lancet Oncol"},{"key":"817_CR7","doi-asserted-by":"publisher","first-page":"e737","DOI":"10.1016\/S2352-3026(20)30251-9","volume":"7","author":"F Passamonti","year":"2020","unstructured":"Passamonti F, Cattaneo C, Arcaini L, Bruna R, Cavo M, Merli F, et al. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020;7:e737\u201345.","journal-title":"Lancet Haematol."},{"key":"817_CR8","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1111\/bjh.16801","volume":"190","author":"F Mart\u00edn\u2010Moro","year":"2020","unstructured":"Mart\u00edn\u2010Moro F, Marquet J, Piris M, Michael BM, S\u00e1ez AJ, Corona M, et al. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies. Br J Haematol. 2020;190:e16\u201320.","journal-title":"Br J Haematol"},{"key":"817_CR9","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/s41591-020-0979-0","volume":"26","author":"EV Robilotti","year":"2020","unstructured":"Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R, Bernardes M, et al. Determinants of COVID-19 disease severity in patients with cancer. Nat Med. 2020;26:1218\u201323.","journal-title":"Nat Med"},{"key":"817_CR10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","volume":"10","author":"M Dai","year":"2020","unstructured":"Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10:783\u201391.","journal-title":"Cancer Discov."},{"key":"817_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/cac2.12077","volume":"40","author":"W Q","year":"2020","unstructured":"Q W, Q C, H Z, B Y, X H, Y Z, et al. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors. Cancer Commun. 2020;40:374\u20139.","journal-title":"Cancer Commun."},{"key":"817_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03244-3","volume":"24","author":"A Shlomai","year":"2020","unstructured":"Shlomai A, Ben-Zvi H, Glusman Bendersky A, Shafran N, Goldberg E, Sklan EH. Nasopharyngeal viral load predicts hypoxemia and disease outcome in admitted COVID-19 patients. Crit Care. 2020;24:539.","journal-title":"Crit Care"},{"key":"817_CR13","doi-asserted-by":"crossref","unstructured":"Westblade LF, Brar G, Pinheiro LC, Paidoussis D, Rajan M, Martin P, et al. SARS-CoV-2 viral load predicts mortality in patients with and without cancer who are hospitalized with COVID-19. Cancer Cell. 2020;38:661\u201371.","DOI":"10.1016\/j.ccell.2020.09.007"},{"key":"817_CR14","doi-asserted-by":"crossref","unstructured":"Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25:2000045.","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045"},{"key":"817_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, M\u00fcller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465\u20139.","journal-title":"Nature"},{"key":"817_CR16","doi-asserted-by":"publisher","first-page":"101791","DOI":"10.1016\/j.tmaid.2020.101791","volume":"36","author":"J-C Lagier","year":"2020","unstructured":"Lagier J-C, Million M, Gautret P, Colson P, Cortaredona S, Giraud-Gatineau A, et al. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine\/azithromycin and other regimens in Marseille, France: a retrospective analysis. Travel Med Infect Dis. 2020;36:101791.","journal-title":"Travel Med Infect Dis"},{"key":"817_CR17","doi-asserted-by":"publisher","first-page":"104615","DOI":"10.1016\/j.jcv.2020.104615","volume":"132","author":"C-A Boutin","year":"2020","unstructured":"Boutin C-A, Grandjean-Lapierre S, Gagnon S, Labb\u00e9 A-C, Charest H, Roger M, et al. Comparison of SARS-CoV-2 detection from combined nasopharyngeal\/oropharyngeal swab samples by a laboratory-developed real-time RT-PCR test and the Roche SARS-CoV-2 assay on a cobas 8800 instrument. J Clin Virol. 2020;132:104615.","journal-title":"J Clin Virol"},{"key":"817_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejca.2020.08.017","volume":"139","author":"A Elkrief","year":"2020","unstructured":"Elkrief A, Desilets A, Papneja N, Cvetkovic L, Groleau C, Lakehal YA, et al. High mortality among hospital-acquired COVID-19 infection in patients with cancer: a multicentre observational cohort study. Eur J Cancer. 2020;139:181\u20137.","journal-title":"Eur J Cancer"},{"key":"817_CR19","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.cell.2020.10.049","volume":"183","author":"VA Avanzato","year":"2020","unstructured":"Avanzato VA, Matson MJ, Seifert SN, Pryce R, Williamson BN, Anzick SL, et al. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell. 2020;183:1901. e9","journal-title":"Cell"},{"key":"817_CR20","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1056\/NEJMc2031670","volume":"383","author":"T Aydillo","year":"2020","unstructured":"Aydillo T, Gonzalez-Reiche AS, Aslam S, van de Guchte A, Khan Z, Obla A, et al. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer. N. Engl J Med. 2020;383:2586\u20138.","journal-title":"N. Engl J Med"},{"key":"817_CR21","doi-asserted-by":"crossref","unstructured":"Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N Engl J Med. 2020;383:2291\u20133.","DOI":"10.1056\/NEJMc2031364"},{"key":"817_CR22","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/infdis\/jiaa446","volume":"222","author":"M Helleberg","year":"2020","unstructured":"Helleberg M, Niemann CU, Moestrup KS, Kirk O, Lebech A-M, Lane C, et al. Persistent COVID-19 in an immunocompromised patient temporarily responsive to two courses of remdesivir therapy. J Infect Dis. 2020;222:1103\u20137.","journal-title":"J Infect Dis"},{"key":"817_CR23","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2020.08.002","volume":"182","author":"A Silvin","year":"2020","unstructured":"Silvin A, Chapuis N, Dunsmore G, Goubet A-G, Dubuisson A, Derosa L, et al. Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell 2020;182:1401. e18","journal-title":"Cell"},{"key":"817_CR24","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41591-020-1038-6","volume":"26","author":"AG Laing","year":"2020","unstructured":"Laing AG, Lorenc A, del Molino del Barrio I, Das A, Fish M, Monin L, et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020;26:1623\u201335.","journal-title":"Nat Med."},{"key":"817_CR25","doi-asserted-by":"crossref","unstructured":"Arunachalam PS, Wimmers F, Mok CKP, Perera RAPM, Scott M, Hagan T, et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. 2020;369:1210\u201320.","DOI":"10.1126\/science.abc6261"},{"key":"817_CR26","first-page":"1","volume":"26","author":"T Takahashi","year":"2020","unstructured":"Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 2020;26:1\u20136.","journal-title":"Nature"},{"key":"817_CR27","doi-asserted-by":"crossref","unstructured":"Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369(6508). https:\/\/science.sciencemag.org\/content\/369\/6508\/eabc8511.","DOI":"10.1126\/science.369.6508.1203-l"},{"key":"817_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cell.2020.08.025","volume":"183","author":"N Kaneko","year":"2020","unstructured":"Kaneko N, Kuo H-H, Boucau J, Farmer JR, Allard-Chamard H, Mahajan VS, et al. Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19. Cell. 2020;183:143\u2013.e13.","journal-title":"Cell"},{"key":"817_CR29","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41587-020-0602-4","volume":"38","author":"RL Chua","year":"2020","unstructured":"Chua RL, Lukassen S, Trump S, Hennig BP, Wendisch D, Pott F, et al. COVID-19 severity correlates with airway epithelium\u2013immune cell interactions identified by single-cell analysis. Nat Biotechnol. 2020;38:970\u20139.","journal-title":"Nat Biotechnol."},{"key":"817_CR30","first-page":"1","volume":"29","author":"J Carvelli","year":"2020","unstructured":"Carvelli J, Demaria O, V\u00e9ly F, Batista L, Benmansour NC, Fares J, et al. Association of COVID-19 inflammation with activation of the C5a\u2013C5aR1 axis. Nature 2020;29:1\u20135.","journal-title":"Nature"},{"key":"817_CR31","unstructured":"Jaafar R, Aherfi S, Wurtz N, Grimaldier C, Hoang VT, Colson P, et al. Correlation between 3790 qPCR positives samples and positive cell cultures including 1941 SARS-CoV-2 isolates. Clin Infect Dis. 2020. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7543373\/."},{"key":"817_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","volume":"581","author":"C Campbell","year":"2020","unstructured":"Campbell C, McKenney PT, Konstantinovsky D, Isaeva OI, Schizas M, Verter J, et al. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature. 2020;581:475\u20139.","journal-title":"Nature."},{"key":"817_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.5530\/ijpi.2020.4.95","volume":"10","author":"PKR Moole","year":"2020","unstructured":"Moole PKR, Papireddypalli JMR. Effect of deoxycholic acid on immune cells\u2014an immunophenotyping analysis of peripheral blood and splenic lymphocytes in CD57 female mice. Int J Pharm Investig. 2020;10:548\u201352.","journal-title":"Int J Pharm Investig."},{"key":"817_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/path.4983","volume":"243","author":"L Sheng","year":"2017","unstructured":"Sheng L, Jena PK, Hu Y, Liu H-X, Nagar N, Kalanetra KM, et al. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation. J Pathol. 2017;243:431\u201341.","journal-title":"J Pathol."},{"key":"817_CR35","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","volume":"577","author":"X Song","year":"2020","unstructured":"Song X, Sun X, Oh SF, Wu M, Zhang Y, Zheng W, et al. Microbial bile acid metabolites modulate gut ROR\u03b3+ regulatory T cell homeostasis. Nature. 2020;577:410\u20135.","journal-title":"Nature"},{"key":"817_CR36","first-page":"9","volume":"15","author":"G Alsaleh","year":"2020","unstructured":"Alsaleh G, Panse I, Swadling L, Zhang H, Richter FC, Meyer A, et al. Autophagy in T cells from aged donors is maintained by spermidine and correlates with function and vaccine responses. eLife 2020;15:9.","journal-title":"eLife"},{"key":"817_CR37","first-page":"3","volume":"11","author":"DJ Puleston","year":"2014","unstructured":"Puleston DJ, Zhang H, Powell TJ, Lipina E, Sims S, Panse I, et al. Autophagy is a critical regulator of memory CD8(+) T cell formation. eLife 2014;11:3.","journal-title":"eLife"},{"key":"817_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.molcel.2019.08.005","volume":"76","author":"H Zhang","year":"2019","unstructured":"Zhang H, Alsaleh G, Feltham J, Sun Y, Napolitano G, Riffelmacher T, et al. Polyamines control eIF5A hypusination, TFEB translation, and autophagy to reverse B cell senescence. Mol Cell. 2019;76:110\u2013.e9. 3","journal-title":"Mol Cell"},{"key":"817_CR39","doi-asserted-by":"crossref","unstructured":"Yeoh YK, Zuo T, Lui GC-Y, Zhang F, Liu Q, Li AY, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698\u2013706.","DOI":"10.1136\/gutjnl-2020-323020"},{"key":"817_CR40","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/trf.13477","volume":"56","author":"S Pa\u00efss\u00e9","year":"2016","unstructured":"Pa\u00efss\u00e9 S, Valle C, Servant F, Courtney M, Burcelin R, Amar J, et al. Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencing. Transfusion. 2016;56:1138\u201347.","journal-title":"Transfusion."},{"key":"817_CR41","doi-asserted-by":"crossref","unstructured":"van Kampen JJA, van de Vijver DAMC, Fraaij PLA, Haagmans BL, Lamers MM, Okba N, et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat Commun. 2021;12:267.","DOI":"10.1038\/s41467-020-20568-4"},{"key":"817_CR42","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus\u2013infected pneumonia. N. Engl J Med. 2020;382:1199\u2013207.","journal-title":"N. Engl J Med"},{"key":"817_CR43","doi-asserted-by":"crossref","unstructured":"Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39:1011\u20139.","DOI":"10.1007\/s10096-020-03874-z"},{"key":"817_CR44","doi-asserted-by":"publisher","first-page":"e0148258","DOI":"10.1371\/journal.pone.0148258","volume":"11","author":"N Lehners","year":"2016","unstructured":"Lehners N, Tabatabai J, Prifert C, Wedde M, Puthenparambil J, Weissbrich B, et al. Long-term shedding of influenza virus, parainfluenza virus, respiratory syncytial virus and nosocomial epidemiology in patients with hematological disorders. PLoS ONE. 2016;11:e0148258.","journal-title":"PLoS ONE"},{"key":"817_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1128\/JCM.02151-12","volume":"51","author":"S Geis","year":"2013","unstructured":"Geis S, Prifert C, Weissbrich B, Lehners N, Egerer G, Eisenbach C, et al. Molecular characterization of a respiratory syncytial virus outbreak in a hematology unit in Heidelberg, Germany. J Clin Microbiol. 2013;51:155\u201362.","journal-title":"J Clin Microbiol."},{"key":"817_CR46","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/bmt.2013.94","volume":"48","author":"N Lehners","year":"2013","unstructured":"Lehners N, Schnitzler P, Geis S, Puthenparambil J, Benz MA, Alber B, et al. Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit. Bone Marrow Transplant. 2013;48:1548\u201353.","journal-title":"Bone Marrow Transplant."},{"key":"817_CR47","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1182\/blood-2009-09-244152","volume":"115","author":"F Milano","year":"2010","unstructured":"Milano F, Campbell AP, Guthrie KA, Kuypers J, Englund JA, Corey L, et al. Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients. Blood. 2010;115:2088\u201394.","journal-title":"Blood."},{"key":"817_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1200\/JOP.18.00567","volume":"15","author":"R El Ramahi","year":"2019","unstructured":"El Ramahi R, Freifeld A. Epidemiology, diagnosis, treatment, and prevention of influenza infection in oncology patients. JOP. 2019;15:177\u201384.","journal-title":"JOP."},{"key":"817_CR49","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ejca.2012.11.003","volume":"49","author":"J P\u00e9ron","year":"2013","unstructured":"P\u00e9ron J, Cropet C, Tredan O, Bachelot T, Ray-Coquard I, Clapisson G, et al. CD4 lymphopenia to identify end-of-life metastatic cancer patients. Eur J Cancer. 2013;49:1080\u20139.","journal-title":"Eur J Cancer"},{"key":"817_CR50","unstructured":"Xu X, Chang XN, Pan HX, Su H, Huang B, Yang M, et al. [Pathological changes of the spleen in ten patients with coronavirus disease 2019(COVID-19) by postmortem needle autopsy]. Zhonghua Bing Li Xue Za Zhi. 2020;49:576\u201382."},{"key":"817_CR51","doi-asserted-by":"publisher","first-page":"107233","DOI":"10.1016\/j.carpath.2020.107233","volume":"48","author":"LM Buja","year":"2020","unstructured":"Buja LM, Wolf DA, Zhao B, Akkanti B, McDonald M, Lelenwa L, et al. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovasc Pathol. 2020;48:107233.","journal-title":"Cardiovasc Pathol"},{"key":"817_CR52","doi-asserted-by":"publisher","first-page":"350","DOI":"10.7326\/M20-2566","volume":"173","author":"SF Lax","year":"2020","unstructured":"Lax SF, Skok K, Zechner P, Kessler HH, Kaufmann N, Koelblinger C, et al. Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center, clinicopathologic case series. Ann Intern. 2020;173:350\u201361.","journal-title":"Ann Intern"},{"key":"817_CR53","doi-asserted-by":"publisher","unstructured":"Pontelli MC, Castro IA, Martins RB, Veras FP, Serra LL, Nascimento DC, et al. Infection of human lymphomononuclear cells by SARS-CoV-2. bioRxiv.2020;2020.07.28.225912. https:\/\/doi.org\/10.1101\/2020.07.28.225912.","DOI":"10.1101\/2020.07.28.225912"},{"key":"817_CR54","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41577-020-0317-2","volume":"20","author":"MD Park","year":"2020","unstructured":"Park MD. Macrophages: a Trojan horse in COVID-19? Nat Rev Immunol. 2020;20:351\u2013351.","journal-title":"Nat Rev Immunol."},{"key":"817_CR55","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","volume":"39","author":"R Channappanavar","year":"2017","unstructured":"Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39:529\u201339.","journal-title":"Semin Immunopathol."},{"key":"817_CR56","doi-asserted-by":"crossref","unstructured":"Westmeier J, Paniskaki K, Karak\u00f6se Z, Werner T, Sutter K, Dolff S, et al. Impaired cytotoxic CD8+ T cell response in elderly COVID-19 patients. mBio. 2020;11. https:\/\/mbio.asm.org\/content\/11\/5\/e02243-20","DOI":"10.1128\/mBio.02243-20"},{"key":"817_CR57","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M, et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007;109:3812\u20139.","journal-title":"Blood"},{"key":"817_CR58","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","volume":"181","author":"CGK Ziegler","year":"2020","unstructured":"Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181:1016. e19","journal-title":"Cell"},{"key":"817_CR59","doi-asserted-by":"crossref","unstructured":"Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science. 2011;331:1565\u201370.","DOI":"10.1126\/science.1203486"},{"key":"817_CR60","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1093\/annonc\/mdx190","volume":"28","author":"MF Sanmamed","year":"2017","unstructured":"Sanmamed MF, Perez-Gracia JL, Schalper KA, Fusco JP, Gonzalez A, Rodriguez-Ruiz ME, et al. Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients. Ann Oncol. 2017;28:1988\u201395.","journal-title":"Ann Oncol"},{"key":"817_CR61","doi-asserted-by":"crossref","unstructured":"Bitterman R, Eliakim\u2010Raz N, Vinograd I, Trestioreanu AZ, Leibovici L, Paul M. Influenza vaccines in immunosuppressed adults with cancer. Cochrane Database of Systematic Rev. 2018;(2). https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD008983.pub3\/full.","DOI":"10.1002\/14651858.CD008983.pub3"},{"key":"817_CR62","doi-asserted-by":"crossref","unstructured":"Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, et al. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. 2018;3(5). https:\/\/insight.jci.org\/articles\/view\/98960.","DOI":"10.1172\/jci.insight.98960"},{"key":"817_CR63","doi-asserted-by":"crossref","unstructured":"Laterre PF, Fran\u00e7ois B, Collienne C, Hantson P, Jeannet R, Remy KE, et al. Association of interleukin 7 immunotherapy with lymphocyte counts among patients with severe coronavirus disease 2019 (COVID-19). JAMA Netw Open. 2020;3(7):e2016485-e2016485.","DOI":"10.1001\/jamanetworkopen.2020.16485"},{"key":"817_CR64","doi-asserted-by":"crossref","unstructured":"Cheng L-L, Guan W-J, Duan C-Y, Zhang N-F, Lei C-L, Hu Y, et al. Effect of recombinant human granulocyte colony-stimulating factor for patients with coronavirus disease 2019 (COVID-19) and lymphopenia: a randomized clinical trial. JAMA Intern Med. 2021;181:71\u201378.","DOI":"10.1001\/jamainternmed.2020.5503"},{"key":"817_CR65","unstructured":"NCT04407689. A Multicenter, Randomized, Double-blinded Placebo-controlled Study of Recombinant Interleukin-7 (CYT107) for Immune Restoration of Hospitalized Lymphopenic Patients With Coronavirus COVID-19 Infection in France and Belgium [Internet]. clinicaltrials.gov; [cit\u00e9 21 janv 2021]. Report No.: NCT04407689. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04407689."},{"key":"817_CR66","unstructured":"NCT04426201. A Multicenter, Randomized, Double-blinded Placebo-controlled Study of Recombinant Interleukin-7 (CYT107) for Immune Restoration of Hospitalized Lymphopenic Patients With Coronavirus COVID-19 Infection. US Oncology Cohort [Internet]. clinicaltrials.gov; [cit\u00e9 21 janv 2021]. Report No.: NCT04426201. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04426201."},{"key":"817_CR67","doi-asserted-by":"publisher","first-page":"101632","DOI":"10.1016\/j.tmaid.2020.101632","volume":"36","author":"S Amrane","year":"2020","unstructured":"Amrane S, Tissot-Dupont H, Doudier B, Eldin C, Hocquart M, Mailhe M, et al. Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: a respiratory virus snapshot. Travel Med Infect Dis. 2020;36:101632.","journal-title":"Travel Med Infect Dis"},{"key":"817_CR68","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s42255-020-0178-9","volume":"2","author":"FF Anh\u00ea","year":"2020","unstructured":"Anh\u00ea FF, Jensen BAH, Varin TV, Servant F, Van Blerk S, Richard D, et al. Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity. Nat Metab. 2020;2:233\u201342.","journal-title":"Nat Metab"},{"key":"817_CR69","doi-asserted-by":"publisher","first-page":"e0142334","DOI":"10.1371\/journal.pone.0142334","volume":"10","author":"J Lluch","year":"2015","unstructured":"Lluch J, Servant F, Pa\u00efss\u00e9 S, Valle C, Vali\u00e8re S, Kuchly C, et al. The characterization of novel tissue microbiota using an optimized 16S metagenomic sequencing pipeline. PLoS ONE. 2015;10:e0142334.","journal-title":"PLoS ONE"},{"key":"817_CR70","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1136\/gutjnl-2019-319123","volume":"69","author":"R Schierwagen","year":"2020","unstructured":"Schierwagen R, Alvarez-Silva C, Servant F, Trebicka J, Lelouvier B, Arumugam M. Trust is good, control is better: technical considerations in blood microbiome analysis. Gut 2020;69:1362\u20133.","journal-title":"Gut"},{"key":"817_CR71","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/bioinformatics\/btx791","volume":"34","author":"F Escudi\u00e9","year":"2018","unstructured":"Escudi\u00e9 F, Auer L, Bernard M, Mariadassou M, Cauquil L, Vidal K, et al. FROGS: find, rapidly, OTUs with galaxy solution. Bioinformatics 2018;34:1287\u201394.","journal-title":"Bioinformatics"},{"key":"817_CR72","doi-asserted-by":"crossref","unstructured":"Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Claer L, et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 2021;13:eabd2223.","DOI":"10.1126\/scitranslmed.abd2223"},{"key":"817_CR73","doi-asserted-by":"publisher","unstructured":"Danlos F-X, Grajeda-Iglesias C, Durand S, Sauvat A, Roumier M, Cantin D, et al. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers. Cell Death Dis. 2021;12:258. https:\/\/doi.org\/10.1038\/s41419-021-03540-y.","DOI":"10.1038\/s41419-021-03540-y"},{"key":"817_CR74","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.4314","volume":"37","author":"E Becht","year":"2019","unstructured":"Becht E, McInnes L, Healy J, Dutertre C-A, Kwok IWH, Ng LG, et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol. 2019;37:38\u201344.","journal-title":"Nat Biotechnol."}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-021-00817-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-021-00817-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-021-00817-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T10:07:16Z","timestamp":1666951636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-021-00817-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["817"],"URL":"https:\/\/doi.org\/10.1038\/s41418-021-00817-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.26.21250357","asserted-by":"object"}]},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,6]]},"assertion":[{"value":"30 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LZ and GK are cofounders of everImmune, a biotech company devoted to the use of commensal microbes for the treatment of cancers. AG and AM as part of the Drug Development Department (DITEP) are Principal\/sub-Investigator of Clinical Trials for Abbvie, Adaptimmune, Aduro Biotech, Agios Pharmaceuticals, Amgen, Argen-X Bvba, Arno Therapeutics, Astex Pharmaceuticals, Astra Zeneca, Astra Zeneca Ab, Aveo, Bayer Healthcare Ag, Bbb Technologies Bv, Beigene, Bioalliance Pharma, Biontech Ag, Blueprint Medicines, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol-Myers Squibb, Bristol-Myers Squibb International Corporation, Ca, Celgene Corporation, Cephalon, Chugai Pharmaceutical Co., Clovis Oncology, Cullinan-Apollo, Daiichi-Sankyo, Debiopharm S.A., Eisai, Eisai Limited, Eli Lilly, Exelixis, Forma Tharapeutics, Gamamabs, Genentech, Gilead Sciences, Glaxosmithkline, Glenmark Pharmaceuticals, H3 Biomedicine, Hoffmann-La Roche Ag, Incyte Corporation, Innate Pharma, Institut De Recherche Pierre Fabre, Iris Servier, Janssen Cilag, Janssen Research Foundation, Kura Oncology, Kyowa Kirin Pharm. Dev., Lilly France, Loxo Oncology, Lytix Biopharma As, Medimmune, Menarini Ricerche, Merck Kgaa, Merck Sharp & Dohme Chibret, Merrimack Pharmaceuticals, Merus, Millennium Pharmaceuticals, Molecular Partners Ag, Nanobiotix, Nektar Therapeutics, Nerviano Medical Sciences, Novartis Pharma, Octimet Oncology Nv, Oncoethix, Oncomed, Oncopeptides, Onyx Therapeutics, Orion Pharma, Oryzon Genomics, Ose Pharma, Pfizer, Pharma Mar, Philogen S.P.A., Pierre Fabre Medicament, Plexxikon, Rigontec Gmbh, Roche, Sanofi Aventis, Sierra Oncology, Sotio A.S, Syros Pharmaceuticals, Taiho Pharma, Tesaro, Tioma Therapeutics, Wyeth Pharmaceuticals France, Xencor, Y\u2019s Therapeutics, Research Grants from Astrazeneca, BMS, Boehringer Ingelheim, Janssen Cilag, Merck, Novartis, Pfizer, Roche, Sanofi. Non-financial support (drug supplied) from Astrazeneca, Bayer, BMS, Boringher Ingelheim, Johnson & Johnson, Lilly, Medimmune, Merck, NH TherAGuiX, Pfizer, Roche. NL reports to be a Speaker at Jazz Pharmaceutical E.D. reports grants and personal fees from ROCHE GENENTECH, grants from SERVIER, grants from ASTRAZENECA, grants and personal fees from MERCK SERONO, grants from BMS, grants from MSD, outside the submitted work. OK is a cofounder of Samsara Therapeutics. F.B. reports personal fees from Astra Zeneca, Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly Oncology,\u00df. Hoffmann-La Roche Ltd, Novartis, Merck, MSD, Pierre Fabre, Pfizer and Takeda, outside the submitted work. J-CS was a full-time employee of Astra Zeneca between September 2017 and December 2019, he reports consultancy: Relay Therapeutics, Gritstone Oncology and shares: Gritstone, Astra Zeneca, Daiichi-Sankyo, outside the submitted work. LA reports consulting fees compensated to institution for Pfizer, Novartis, Bristol Myer Squibb, Ipsen, Roche, MSD, Astra Zeneca, Merck, Amgen, Astellas, Exelixis, Corvus Pharmaceuticals, Peloton Therapeutics, outside the submitted work. FS reports consulting fees from AMGEN, Roche, Chugai, Mylan, Mundi Pharma, Leo Pharma, Pierre Fabre Oncology, Helsinn, MSD, Pfizer, BMS, outside the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ONCOVID trial was conducted in accordance with Good Clinical Practice guidelines and the provisions of the Declaration of Helsinki. All patients provided written informed consent. Protocol approval was obtained from an independent ethics committee (ethics protocol number EudraCT No: 2020-001250-21). The protocol is available with the full text of this article at\n                      \n                      . The part of the research including healthcare workers was conducted in compliance with General Data Protection Regulation (GDPR) and the French Data Protection Authority\u2019s recommendation about Data Protection in clinical researches. Gustave Roussy Data Protection Officer (DPO) has evaluated this project and sent to the principal investigator a formalized operational action plan about data protection compliance. The Cancer_FR2 cohort used individuals from a clinical study approved by the IHU M\u00e9diterran\u00e9e Infections review board committee (M\u00e9diterran\u00e9e Infection No.: 2020-021). The Cancer_CA cohort used individuals from a clinical study approved by the institutional ethics committee at each site (Ethics number: MP-02- 2020-8911 and H20-00892). The Cancer_FR1_CR was also declared to the Gustave Roussy Cancer Centre\u2019s DPO and registered on the website of the French Healthcare Data Institute (declaration number: MR4911200520).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}